The chemoattractant receptor GPR15 directs the homing of T cells to the colon; however, GRP15 expression differs in the effector and regulatory T cell subsets of humans versus those of mice. These findings have profound implications for the potential targeting of GRP15 for therapeutic intervention.
References
Nguyen, L.P. et al. Nat. Immunol. 16, 207–213 (2015).
Kim, S.V. et al. Science 340, 1456–1459 (2013).
Mosli, M.H., Rivera-Nieves, J. & Feagan, B.G. Drugs 74, 297–311 (2014).
Poole, R.M. Drugs 74, 1293–1303 (2014).
Keshav, S. et al. PLoS ONE 8, e60094 (2013).
Heiber, M. et al. Genomics 32, 462–465 (1996).
Deng, H.K. & Unutmaz, D. KewalRamani, V.N. & Littman, D.R. Nature 388, 296–300 (1997).
Farzan, M. et al. J. Biol. Chem. 272, 6854–6857 (1997).
Soriano, A. et al. Lab. Invest. 80, 1541–1551 (2000).
Fiorucci, S. et al. Immunity 17, 769–780 (2002).
Wang, C. et al. Inflamm. Bowel Dis. 16, 1751–1762 (2010).
Denning, T.L., Kim, G. & Kronenberg, M. J. Immunol. 174, 7487–7491 (2005).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.L.V. is employed by Biogen Idec.
Rights and permissions
About this article
Cite this article
Bilsborough, J., Viney, J. GPR15: a tale of two species. Nat Immunol 16, 137–139 (2015). https://doi.org/10.1038/ni.3084
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.3084
- Springer Nature America, Inc.